C.F.R. homeSearch C.F.R.
C.F.R.Title 42Chapter IV—Centers for Medicare & Medicaid Services, Department of Health and Human ServicesSubchapter G—Standards and CertificationPart 482—Conditions of Participation for HospitalsSubpart C—Basic Hospital Functions

42 C.F.R. § 482.25 (2026)

Condition of participation: Pharmaceutical services

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 2001–2003 2citing cases
At a glance

Courts have cited this section in 2 opinions since 2001. The most litigated part is subsection (h)(2) (1 case).

The hospital must have pharmaceutical services that meet the needs of the patients. The institution must have a pharmacy directed by a registered pharmacist or a drug storage area under competent supervision. The medical staff is responsible for developing policies and procedures that minimize drug errors. This function may be delegated to the hospital's organized pharmaceutical service.

(a) Standard: Pharmacy management and administration. The pharmacy or drug storage area must be administered in accordance with accepted professional principles.

(1) A full-time, part-time, or consulting pharmacist must be responsible for developing, supervising, and coordinating all the activities of the pharmacy services.

(2) The pharmaceutical service must have an adequate number of personnel to ensure quality pharmaceutical services, including emergency services.

(3) Current and accurate records must be kept of the receipt and disposition of all scheduled drugs.

(b) Standard: Delivery of services. In order to provide patient safety, drugs and biologicals must be controlled and distributed in accordance with applicable standards of practice, consistent with Federal and State law.

(1) All compounding, packaging, and dispensing of drugs and biologicals must be under the supervision of a pharmacist and performed consistent with State and Federal laws.

(2)(i) All drugs and biologicals must be kept in a secure area, and locked when appropriate.

(ii) Drugs listed in Schedules II, III, IV, and V of the Comprehensive Drug Abuse Prevention and Control Act of 1970 must be kept locked within a secure area.

(iii) Only authorized personnel may have access to locked areas.

(3) Outdated, mislabeled, or otherwise unusable drugs and biologicals must not be available for patient use.

(4) When a pharmacist is not available, drugs and biologicals must be removed from the pharmacy or storage area only by personnel designated in the policies of the medical staff and pharmaceutical service, in accordance with Federal and State law.

(5) Drugs and biologicals not specifically prescribed as to time or number of doses must automatically be stopped after a reasonable time that is predetermined by the medical staff.

(6) Drug administration errors, adverse drug reactions, and incompatibilities must be immediately reported to the attending physician and, if appropriate, to the hospital's quality assessment and performance improvement program.

(7) Abuses and losses of controlled substances must be reported, in accordance with applicable Federal and State laws, to the individual responsible for the pharmaceutical service, and to the chief executive officer, as appropriate.

(8) Information relating to drug interactions and information of drug therapy, side effects, toxicology, dosage, indications for use, and routes of administration must be available to the professional staff.

(9) A formulary system must be established by the medical staff to assure quality pharmaceuticals at reasonable costs.

[51 FR 22042, June 17, 1986; 51 FR 27848, Aug. 4, 1986; 71 FR 68694, Nov. 27, 2006; 77 FR 29075, May 16, 2012]
The 2 cases that cite 42 C.F.R. § 482.25 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENWoodstock Care Ctr. v. Thompson, 363 F.3d 583 (6th Cir. 2003).
cites § 482.25 1×cited by 9 cases
Where it cites § 482.25
“In it, Woodstock alleged that the DAB’s decision was not supported by rehable, probative, and substantial evidence, that the rationale supporting the decision was arbitrary and capricious, that the decision was contrary to 42 C.F.R. § 482.25 (h)(2), and that it violated…”
Later courts cite it for
“if supported by substantial evidence on the record considered as a whole.” · 5 citing courts
2
GREENWoodstock Care Ctr. v. Thompson, 161 F. Supp. 2d 813 (S.D. Ohio 2001).
cites § 482.25 1×subsections: (h)(2)cited by 1 case
Where it cites § 482.25
“In its Amended Complaint, Woodstock challenges an administrative finding that it failed to comply with the “quality of care” requirements of 42 C.F.R. 482.25(h)(2) and a finding that its level of non-compliance resulted in “immediate jeopardy.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

By subsection
(h)(2)1 case
Woodstock Care Ctr. v. Thompson, 161 F. Supp. 2d 813 (S.D. Ohio 2001).“In its Amended Complaint, Woodstock challenges an administrative finding that it failed to comply with the “quality of care” requirements of 42 C.F.R. 482.25(h)(2) and a finding that its level of non-compliance resulted in “immediate jeopardy.”
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com